erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Kudoh S [Pathophysiology of diffuse panbronchiolitis and progress of the therapy]. 1996 Nihon Kyobu Shikkan Gakkai Zasshi pmid:9216178
Tenson T et al. Erythromycin resistance peptides selected from random peptide libraries. 1997 J. Biol. Chem. pmid:9211885
Itoh Z Motilin and clinical application. 1997 Peptides pmid:9210180
Kluger MT Erythromycin--a pro-kinetic and pro-arrhythmogenic agent. 1997 Anaesth Intensive Care pmid:9209631
Nakata K et al. [Suppressive effect of clarithromycin on the production of verotoxin by E. coli O157]. 1997 Kansenshogaku Zasshi pmid:9209125
Nakamura A [Prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in a children's hospital]. 1997 Kansenshogaku Zasshi pmid:9209123
Vagliasindi M Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin. 1997 Int J Clin Pharmacol Ther pmid:9208340
Lagasse JP et al. [Acute reversible pan-dysautonomia: effect of erythromycin on gastrointestinal involvement]. 1997 Gastroenterol. Clin. Biol. pmid:9208000
Gleason PP et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. 1997 JAMA pmid:9207335
Rampe D and Murawsky MK Blockade of the human cardiac K+ channel Kv1.5 by the antibiotic erythromycin. 1997 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9205959
Pacini N et al. Antimicrobial susceptibility tests on anaerobic oral mixed cultures in periodontal diseases. 1997 J. Clin. Periodontol. pmid:9205919
Palacín C et al. In vitro anti-Helicobacter pylori activity of ebrotidine. 1997 Arzneimittelforschung pmid:9205746
Monsieur I et al. Severe community-acquired pneumonia caused by atypical organisms. 1997 Acta Clin Belg pmid:9204587
Rosser EJ German shepherd dog pyoderma: a prospective study of 12 dogs. 1997 Jul-Aug J Am Anim Hosp Assoc pmid:9204474
Caron D et al. Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. 1997 J. Am. Acad. Dermatol. pmid:9204088
Kabir I et al. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. 1996 J Diarrhoeal Dis Res pmid:9203786
Ishii M et al. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis. 1997 Diabetes Care pmid:9203450
Son R et al. Antibiotic resistance and plasmid profile of Aeromonas hydrophila isolates from cultured fish, Telapia (Telapia mossambica). 1997 Lett. Appl. Microbiol. pmid:9203404
Fons M et al. Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance. 1997 Plasmid pmid:9200223
Brückner R Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. 1997 FEMS Microbiol. Lett. pmid:9198277
Baumüller A et al. [Bacterial prostatitis--therapeutic principles]. 1977 Z Urol Nephrol pmid:919805
Rendell DK and Callinan AP Comparison of erythromycin and oxytetracycline for the treatment of virulent footrot in grazing sheep. 1997 Aust. Vet. J. pmid:9196823
Shimada T et al. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. 1997 Arch. Toxicol. pmid:9195021
Pacifico L et al. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. 1997 Pediatr. Infect. Dis. J. pmid:9194108
Huovinen P et al. The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance. 1997 Ciba Found. Symp. pmid:9189633
Hanada E et al. Determination of erythromycin concentrations in rat plasma and liver by high-performance liquid chromatography with amperometric detection. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9188840
Reines HD et al. Use of standard colon preparation in elective colectomy for carcinoma of the colon. 1977 Nov-Dec Rev Surg pmid:918536
Roblin PM et al. In-vitro activity of dirithromycin against Chlamydia pneumoniae. 1997 J. Antimicrob. Chemother. pmid:9184366
Xia HX et al. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. 1996 J. Antimicrob. Chemother. pmid:9182104
Roe DE et al. Mobile rRNA methylase genes coding for erythromycin resistance in Actinobacillus actinomycetemcomitans. 1996 J. Antimicrob. Chemother. pmid:9182102
Hofstetter A [Mycoplasma infections of the genito-urinary tract (author's transl)]. 1977 Schweiz. Rundsch. Med. Prax. pmid:918003
Resnick J et al. Delayed gastric emptying and postoperative ileus after nongastric abdominal surgery: part II. 1997 Am. J. Gastroenterol. pmid:9177505
Young H et al. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. 1997 Int J STD AIDS pmid:9175650
Rybak MJ et al. Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. 1997 Antimicrob. Agents Chemother. pmid:9174199
Gibert Agulló A et al. [Generalized acute exanthematous pustulosis: two case reports]. 1997 An. Esp. Pediatr. pmid:9173852
Berg-Candolfi M et al. Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression. 1996 Xenobiotica pmid:9173679
Piérard GE [Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne]. 1997 Rev Med Liege pmid:9173479
Koch B et al. Construction of specific erythromycin resistance mutations in the temperate lactococcal bacteriophage TP901-1 and their use in studies of phage biology. 1997 Appl. Environ. Microbiol. pmid:9172365
Leloup L et al. Single-crossover integration in the Lactobacillus sake chromosome and insertional inactivation of the ptsI and lacL genes. 1997 Appl. Environ. Microbiol. pmid:9172327
Somkuti GA et al. Molecular properties of the erythromycin resistance plasmid pPV141 from Staphylococcus chromogenes. 1997 Plasmid pmid:9169203
Scalabrino G et al. Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. 1997 Exp. Neurol. pmid:9168827
Lin JC and Quasny HA QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. 1997 May-Jun Pharmacotherapy pmid:9165570
Cheng CL et al. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. 1997 Clin. Pharmacol. Ther. pmid:9164415
Yanagihara K et al. [Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa]. 1997 Kansenshogaku Zasshi pmid:9164089
Sugihara E Effect of macrolide antibiotics on neutrophil function in human peripheral blood. 1997 Kansenshogaku Zasshi pmid:9164088
Hessler PE et al. Isolation of isoflavones from soy-based fermentations of the erythromycin-producing bacterium Saccharopolyspora erythraea. 1997 Appl. Microbiol. Biotechnol. pmid:9163954
Heaton MP and Handwerger S Conjugative mobilization of a vancomycin resistance plasmid by a putative Enterococcus faecium sex pheromone response plasmid. 1995 Microb. Drug Resist. pmid:9158753
Matsuhashi M et al. Cellular signals regulating antibiotic sensitivities of bacteria. 1996 Microb. Drug Resist. pmid:9158728
Mitsuyama T et al. Inhibition by erythromycin of human pulmonary artery endothelial cell injury induced by human neutrophils. 1997 Respiration pmid:9154672
Carroll KC et al. Susceptibility of beta-hemolytic streptococci to nine antimicrobial agents among four medical centers in Salt Lake City, Utah, USA. 1997 Diagn. Microbiol. Infect. Dis. pmid:9154408